Long-lasting infection-control solution now available in Australia

Friday, 12 February, 2021

Long-lasting infection-control solution now available in Australia

SurfaceWise2, a hospital-grade disinfectant that makes surfaces hostile to germs for up to three months, has been launched in Australia by Allied BioServices. The Therapeutic Goods Administration (TGA)-listed product was developed to provide always-on antimicrobial protection against 99.9% of germs, bacteria and COVID-19.

Every year, up to 180,000 Australians suffer healthcare-associated infections (HAIs), which result in prolonged hospital stays and occupation of two million hospital beds. It is estimated that up to 70% of HAIs are preventable.

SurfaceWise2 has been scientifically proven to protect surfaces in a real-world environment against 99.99% of germs (including coronavirus) for up to three months, with independently verified results published in peer-reviewed journals. The TGA has listed the product for use against COVID-19, germs and bacteria. To see how the product works, click here.

Internationally recognised microbiologist and Professor of Environmental Microbiology Dr Charles Gerba said, “SurfaceWise2 is the next generation of infection control. Our generation spends more time indoors. We have larger schools, bigger buildings, we travel further and push more buttons than any other generation in history. This means that our generation creates the perfect storm for pandemics, and we will see more pandemics in the future. We have had one plague after another over the last 20 years including HIV to Zika, Ebola, SARS, MERS, Swine flu and bird flu. Viruses evolve rapidly, which is why we need to control the infection by making surfaces hostile to germs, including the common cold and gastroenteritis.”

According to research undertaken by Dr Gerba, germ hotspots include:

  • Office phones followed by desktops, laptops or tablets.
  • Countertops in shared break rooms where food is prepared.
  • The ground floor lift button.

Bathrooms are not as bad as we think, as most people only use the bathroom a few times per day and they wash their hands. Our hands are the greatest spreader of germs as we sneeze and then touch surfaces and our face. Adults touch their face 16–24 times per hour. Young children touch their faces as often as 40–50 times per hour.

Traditional cleaning products such as disinfectants are momentary solutions — surfaces become immediately recontaminated as soon as someone touches, coughs or sneezes on that surface. SurfaceWise2 is a non-toxic coating that can be sprayed onto a variety of surfaces to provide always-on protection. The technology is highly residual after a single coating.

The Australian operations of Allied BioServices is being spearheaded by CEO Tim Smith and Chief Executive, Channels, Dan Ode.

“SurfaceWise2 is the only solution to have been tested in real-world scenarios — not just in a lab; that has been independently reviewed and published in multiple leading medical journals,” Tim Smith said. “We are excited to be able to bring this protection to Australians.

“SurfaceWise2 should be deployed in the places and spaces where people are at most risk of catching infectious diseases such as hospitals, aged care, public transport, aviation, fitness centres, commercial buildings and government facilities.”

Allied BioServices works closely with organisations to deploy an infection control solution where a deep clean will be undertaken, which is then followed by a specialised application of SurfaceWise2 for maximum protection of surfaces.

SurfaceWise2 has already been piloted with Anytime Fitness, resulting in a 90%+ reduction in germs over a three-month period compared with pre-application testing.

Related News

Program to improve menopause support, treatment

A new program by Monash University aims to improve support and treatment for women experiencing...

Extended funding for ovarian cancer project

The federal government has announced $2.96 million funding for the next phase of the TRACKFORWARD...

Early exposure to antibiotics can increase risk of asthma: study

In Australia, 2.7 million people live with asthma and for 45% of these people, their asthma is...

  • All content Copyright © 2024 Westwick-Farrow Pty Ltd